Cell therapy and oncology–focused Carisma Therapeutics started layoffs late last year. Now the company plans to wind down ...

In preliminary clinical trials to date and previous clinical trials with the oral formulation, GRI-0621 has been shown to improve fibrosis in multiple disease models and improve liver function tests ...

After a year of stripping back its head count and pipeline, Carisma Therapeutics is now cutting down to the bone and laying ...

GRI Bio (GRI) reported interim safety results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary ...

A biotech company advancing next-generation precision therapeutics for fibrosis. Forth Therapeutics (Forth Tx) is a ...

Cannabidiol (CBD) may help protect the liver from stress-induced injury by targeting inflammation, oxidative stress, and mitochondrial damage, according to a new study published by the journal ...

The following is a summary of "Role of the advanced lung cancer inflammation index (ALI) in the risk of liver fibrosis and ...

The following is a summary of "Clinical characteristics and management of long survivors in extensive stage small cell lung ...